InvestorsHub Logo
Followers 62
Posts 7555
Boards Moderated 1
Alias Born 01/02/2003

Re: HDGabor post# 382077

Saturday, 07/02/2022 8:37:28 PM

Saturday, July 02, 2022 8:37:28 PM

Post# of 426441
HDG...QUOTE..."None of the most discussed topics - ongoing studies, STAT article, management, etc. - are important on a real (long-) term"

Judging from Denner's past history as an activist investor, it is probably his goal to arrange, in the near term, something that should have done years ago...i.e. to sell Amarin to a BP.

The outcomes of the topics up for discussion here are relevant as to the timing and price to be obtained for the shareholders from the sale of the company...


P.S....It was my mistake to interpret AHA as meaning America Hospital Association rather than American Heart Association...and,this led me to report on the wrong dates for the meeting where the Respect study is to be discussed.

Thank you Nsleven for clearing that up...Respect will be reported in November, rather than in July...assuming the study is accepted to be reported at the meeting...The Respect and Mitigate studies should do a lot to quell the recent absurd conspiracy of chronic Vascepa opponents to discredit the Reduce It study by using the mineral oil placebo as the reason for the excellent results achieved by Vascepa in reducing CVD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News